Mechanism for seasonal vaccine effect on pandemic H1N1 risk remains uncertain

Clinical Infectious Diseases

Volumn 52, Issue 6, 2011, Pages 831-832

  Skowronski, Danuta M ^a   Janjua, Naveed Z ^a   Hottes, Travis S ^a   De Serres, Gaston ^b  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PLACEBO; TRIVALENT INFLUENZA VACCINE; UNCLASSIFIED DRUG;

CROSS REACTION; DILUTION; DRUG EFFICACY; DRUG SAFETY; HOUSEHOLD; HUMAN; IMMUNITY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LETTER; PRIORITY JOURNAL; RISK FACTOR; SEASONAL VARIATION; TREATMENT OUTCOME; UNCERTAINTY; VIRUS STRAIN;

ADOLESCENT; ADULT; CHILD; CROSS PROTECTION; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; RISK FACTORS; VACCINATION;

EID: 79953737766     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir036     Document Type: Letter

References (7)

1. Cowling BJ, Ng S, Ma ESK, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010; 51:1370-1379.
2. Glezen WP. How did the 2008-09 seasonal influenza vaccine affect the pandemic? Clin Infect Dis 2010; 51:1380-1382.
3. Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010; 7:e1000259.
4. Janjua NZ, Skowronski DM, Hottes TS, et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010; 51:1017-1027.
5. Vincent AL, Lager KM, Janke BH, Gramer MR, Richt JA. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet Microbiol 2008; 126:310-323. (Pubitemid 350199605)
6. Kobinger GP, Meunier I, Patel A, et al. Effi- cacy assessment of commercially available and candidate vaccines against a swine-origin H1N1 virus. J Infect Dis 2010; 201:1000-1006.
7. Crum-Cianflone NF, Blair PJ, Faix D, et al. Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A among United States military beneficiaries. Clin Infect Dis 2009; 49: 1801-1810.